Results 11 to 20 of about 16,979 (251)

BORDERLINE OVARIAN TUMOR AND PREGNANCY [PDF]

Romanian Journal of Medical Practice, 2019
We present a case of a 26 year-old pregnant woman, who was diagnosed a serous borderline tumor of the ovary, two years ago. CA 125, CA 19-9 and HE4 was within the normal range values.
Astrit M. Gashi, Jakup Ismajli, Xhevdet Gojnovci   +2 more
doaj   +2 more sources

Controversies in borderline ovarian tumors [PDF]

Journal of Gynecologic Oncology, 2015
Borderline ovarian tumors (BOTs) represent about 15% to 20% of all ovarian malignancies and differ from invasive ovarian cancers (IOCs) by many characters. Historically, standard management of BOT is peritoneal washing cytology, hysterectomy, bilateral salpingo-oophorectomy, omentectomy, complete peritoneal resection of macroscopic lesions; in case of ...
Seong, Seok Ju, Kim, Da Hee, Kim, Mi Kyoung, Song, Taejong   +3 more
openaire   +2 more sources

Health disparities in chronic liver disease

Hepatology, EarlyView., 2022
Abstract The syndemic of hazardous alcohol consumption, opioid use, and obesity has led to important changes in liver disease epidemiology that have exacerbated health disparities. Health disparities occur when plausibly avoidable health differences are experienced by socially disadvantaged populations.
Ani Kardashian, Marina Serper, Norah Terrault, Lauren D. Nephew   +3 more
wiley   +1 more source

Borderline Ovarian Tumor

Journal Obgin Emas, 2021
Ovarian borderline tumors are a group of pathologic tumors that exhibit a higher proliferative activity when compared to benign tumors. Due to the absence of a screening method, ovarian cancer is often diagnosed when the patient already has a complaint, or at an advanced stage.
Gistin Husnul Khatimah, Andi Friadi
openaire   +1 more source

Borderline ovarian tumors

Archive of Oncology, 2006
Borderline ovarian tumors are classified between benign cystadenoma and malignant cystadenocarcinoma. They are characterized as malignant tumors by histopathological features, which make them different from the benign ones. These tumors are commonly diagnosed at the early disease stage. The treatment of these tumors is surgical.
Mastilović Katarina, Ivković-Kapicl Tatjana, Živaljević Milica, Rajović Jelka, Ninčić Dejan   +4 more
openaire   +4 more sources

Management of borderline ovarian tumors

Annals of Oncology, 2016
Borderline ovarian tumors (BOT) are epithelial tumors of the ovaries with both malignant and non-malignant aspects. On the one hand, they are characterized by cellular proliferation and nuclear atypia but, on the other hand, they usually do not show infiltrative growth pattern.
A, du Bois, F, Trillsch, S, Mahner, F, Heitz, P, Harter   +4 more
openaire   +2 more sources

Update of Laparoscopic Surgery in Borderline Ovarian Tumor: Systematic Review

Clinical and Experimental Obstetrics & Gynecology, 2023
Background: Borderline ovarian tumor (BOT) predominantly affects young women and is often diagnosed at an early stage. BOT accounts for 15% of all epithelial tumors.
Isabella Rotondella, Elisa Scarpelli, Giulia Martignon, Davide Scebba, Luciano Monfardini, Michela Gaiano, Alessandra De Finis, Martina Leotta, Carlotta Montrucchio, Asya Gallinelli, Stefano Cianci, Stefano Restaino, Giuseppe Vizzielli, Vito Andrea Capozzi   +13 more
doaj   +1 more source

Borderline ovarian tumors [PDF]

Asia-Pacific Journal of Clinical Oncology, 2007
AbstractBorderline ovarian tumors account for approximately 15% of all epithelial ovarian tumors. In the early 1970s, borderline tumors were categorized as either serous or mucinous with overall survival rates of 75–90%. Since then, it has been recognized that the two categories are heterogonous.
Fatemeh GHAEMMAGHAMI, Tahereh ASHRAF‐GANJOOIE, Giti IRAVANLOO   +2 more
openaire   +1 more source

European guidelines from the EHTG and ESCP for Lynch syndrome: an updated third edition of the Mallorca guidelines based on gene and gender

BJS (British Journal of Surgery), EarlyView., 2020
Recommendations for clinical and molecular identification of LS, surgical and endoscopic management of LS‐associated colorectal cancer and preventive measures for cancer were produced. The emphasis was on surgical and gastroenterological aspects of the cancer spectrum.
T. T. Seppälä, A. Latchford, I. Negoi, A. Sampaio Soares, R. Jimenez‐Rodriguez, L. Sánchez‐Guillén, D. G. Evans, N. Ryan, E. J. Crosbie, M. Dominguez‐Valentin, J. Burn, M. Kloor, M. von Knebel Doeberitz, F. J. B. van Duijnhoven, P. Quirke, J. R. Sampson, P. Møller, G. Möslein, on behalf of the European Hereditary Tumour Group (EHTG) and European Society of Coloproctology (ESCP)   +18 more
wiley   +1 more source

PAX2, PAX8, and PR are correlated with ovarian seromucinous borderline tumor with endometriosis

Journal of Ovarian Research, 2022
Background Ovarian “seromucinous carcinoma” has been recently removed in 2020 5th Edition of WHO classification of Female Genital Tumors and is considered as a subtype of endometrioid carcinoma with mucinous differentiation, while “seromucinous ...
Bo Seong Yun, Seyeon Won, Ju-Hyun Kim, Nara Lee, Miseon Kim, Mi Kyoung Kim, Mi-La Kim, Yong Wook Jung, Ji Young Kim, Seok Ju Seong, Eunah Shin   +10 more
doaj   +1 more source